These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 27173425)

  • 1. Experimentally induced diabetes worsens neuropathology, but not learning and memory, in middle aged 3xTg mice.
    Hayashi-Park E; Ozment BN; Griffith CM; Zhang H; Patrylo PR; Rose GM
    Behav Brain Res; 2017 Mar; 322(Pt B):280-287. PubMed ID: 27173425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SLOH, a carbazole-based fluorophore, mitigates neuropathology and behavioral impairment in the triple-transgenic mouse model of Alzheimer's disease.
    Wu X; Kosaraju J; Zhou W; Tam KY
    Neuropharmacology; 2018 Mar; 131():351-363. PubMed ID: 29309769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tau passive immunization inhibits not only tau but also Aβ pathology.
    Dai CL; Tung YC; Liu F; Gong CX; Iqbal K
    Alzheimers Res Ther; 2017 Jan; 9(1):1. PubMed ID: 28073379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Traumatic brain injury accelerates amyloid-β deposition and impairs spatial learning in the triple-transgenic mouse model of Alzheimer's disease.
    Shishido H; Kishimoto Y; Kawai N; Toyota Y; Ueno M; Kubota T; Kirino Y; Tamiya T
    Neurosci Lett; 2016 Aug; 629():62-67. PubMed ID: 27373531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term dantrolene treatment reduced intraneuronal amyloid in aged Alzheimer triple transgenic mice.
    Wu Z; Yang B; Liu C; Liang G; Eckenhoff MF; Liu W; Pickup S; Meng Q; Tian Y; Li S; Wei H
    Alzheimer Dis Assoc Disord; 2015; 29(3):184-191. PubMed ID: 25650693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of the superoxide dismutase/catalase mimetic EUK-207 in a mouse model of Alzheimer's disease: protection against and interruption of progression of amyloid and tau pathology and cognitive decline.
    Clausen A; Xu X; Bi X; Baudry M
    J Alzheimers Dis; 2012; 30(1):183-208. PubMed ID: 22406441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term central pathology and cognitive impairment are exacerbated in a mixed model of Alzheimer's disease and type 2 diabetes.
    Infante-Garcia C; Ramos-Rodriguez JJ; Galindo-Gonzalez L; Garcia-Alloza M
    Psychoneuroendocrinology; 2016 Mar; 65():15-25. PubMed ID: 26708068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nobiletin, a citrus flavonoid, improves cognitive impairment and reduces soluble Aβ levels in a triple transgenic mouse model of Alzheimer's disease (3XTg-AD).
    Nakajima A; Aoyama Y; Shin EJ; Nam Y; Kim HC; Nagai T; Yokosuka A; Mimaki Y; Yokoi T; Ohizumi Y; Yamada K
    Behav Brain Res; 2015 Aug; 289():69-77. PubMed ID: 25913833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Staging of cognitive deficits and neuropathological and ultrastructural changes in streptozotocin-induced rat model of Alzheimer's disease.
    Knezovic A; Osmanovic-Barilar J; Curlin M; Hof PR; Simic G; Riederer P; Salkovic-Petrisic M
    J Neural Transm (Vienna); 2015 Apr; 122(4):577-92. PubMed ID: 25808906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin-resistant brain state after intracerebroventricular streptozotocin injection exacerbates Alzheimer-like changes in Tg2576 AbetaPP-overexpressing mice.
    Plaschke K; Kopitz J; Siegelin M; Schliebs R; Salkovic-Petrisic M; Riederer P; Hoyer S
    J Alzheimers Dis; 2010; 19(2):691-704. PubMed ID: 20110613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spatial Memory Impairment is Associated with Intraneural Amyloid-β Immunoreactivity and Dysfunctional Arc Expression in the Hippocampal-CA3 Region of a Transgenic Mouse Model of Alzheimer's Disease.
    Morin JP; Cerón-Solano G; Velázquez-Campos G; Pacheco-López G; Bermúdez-Rattoni F; Díaz-Cintra S
    J Alzheimers Dis; 2016; 51(1):69-79. PubMed ID: 26836189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early detection of cognitive deficits in the 3xTg-AD mouse model of Alzheimer's disease.
    Stover KR; Campbell MA; Van Winssen CM; Brown RE
    Behav Brain Res; 2015 Aug; 289():29-38. PubMed ID: 25896362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-fat diet-induced memory impairment in triple-transgenic Alzheimer's disease (3xTgAD) mice is independent of changes in amyloid and tau pathology.
    Knight EM; Martins IV; Gümüsgöz S; Allan SM; Lawrence CB
    Neurobiol Aging; 2014 Aug; 35(8):1821-32. PubMed ID: 24630364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuropep-1 ameliorates learning and memory deficits in an Alzheimer's disease mouse model, increases brain-derived neurotrophic factor expression in the brain, and causes reduction of amyloid beta plaques.
    Shin MK; Kim HG; Baek SH; Jung WR; Park DI; Park JS; Jo DG; Kim KL
    Neurobiol Aging; 2014 May; 35(5):990-1001. PubMed ID: 24268884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sleep deprivation impairs memory, tau metabolism, and synaptic integrity of a mouse model of Alzheimer's disease with plaques and tangles.
    Di Meco A; Joshi YB; Praticò D
    Neurobiol Aging; 2014 Aug; 35(8):1813-20. PubMed ID: 24629673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacologic reversal of neurogenic and neuroplastic abnormalities and cognitive impairments without affecting Aβ and tau pathologies in 3xTg-AD mice.
    Blanchard J; Wanka L; Tung YC; Cárdenas-Aguayo Mdel C; LaFerla FM; Iqbal K; Grundke-Iqbal I
    Acta Neuropathol; 2010 Nov; 120(5):605-21. PubMed ID: 20697724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tetrahydrobiopterin Improves Recognition Memory in the Triple-Transgenic Mouse Model of Alzheimer's Disease, Without Altering Amyloid-β and Tau Pathologies.
    Fanet H; Tournissac M; Leclerc M; Caron V; Tremblay C; Vancassel S; Calon F
    J Alzheimers Dis; 2021; 79(2):709-727. PubMed ID: 33337360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The BET-Bromodomain Inhibitor JQ1 Reduces Inflammation and Tau Phosphorylation at Ser396 in the Brain of the 3xTg Model of Alzheimer's Disease.
    Magistri M; Velmeshev D; Makhmutova M; Patel P; Sartor GC; Volmar CH; Wahlestedt C; Faghihi MA
    Curr Alzheimer Res; 2016; 13(9):985-95. PubMed ID: 27117003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Females exhibit more extensive amyloid, but not tau, pathology in an Alzheimer transgenic model.
    Hirata-Fukae C; Li HF; Hoe HS; Gray AJ; Minami SS; Hamada K; Niikura T; Hua F; Tsukagoshi-Nagai H; Horikoshi-Sakuraba Y; Mughal M; Rebeck GW; LaFerla FM; Mattson MP; Iwata N; Saido TC; Klein WL; Duff KE; Aisen PS; Matsuoka Y
    Brain Res; 2008 Jun; 1216():92-103. PubMed ID: 18486110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hydrogen sulfide slows down progression of experimental Alzheimer's disease by targeting multiple pathophysiological mechanisms.
    Giuliani D; Ottani A; Zaffe D; Galantucci M; Strinati F; Lodi R; Guarini S
    Neurobiol Learn Mem; 2013 Sep; 104():82-91. PubMed ID: 23726868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.